Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

The journal Nature publishes a review of severe COVID-19-related factors with the participation of Vall d’Hebron

The publication summarises the main results showing that at least 20% of cases of severe pneumonia after SARS-CoV-2 infection are explained by genetic and immunological anomalies.

News

A Vall d’Hebron study relates the impact of obesity to cognitive impairment

The mechanisms in obesity that cause mild cognitive impairment are similar to those of type 2 diabetes. Fat is a powerful cerebral toxin and risk factor: it causes delayed reaction times in both executive function and attention.

News

Researchers identify a molecule that could be involved in the formation of bone metastases in prostate cancer

A group of researchers from Vall d’Hebron Research, IDIBELL and UB has identified a molecule involved in bone metastasis associated with prostate cancer that could be useful in the design of new therapies for its treatment.

News

The European RBDCOV project will study HIPRA’s COVID-19 vaccine in children, adolescents and immunocompromised patients

Funded by the Horizon Europe programme, RBDCOV will test the efficacy, tolerability, and safety of the vaccine against the different variants of COVID-19 using a recombinant protein.

News

Vall d'Hebron identifies that patients with diabetes and myocardial insulin resistance have high cardiovascular risk

Researchers have detected for the first time that people with type 2 diabetes who have insulin resistance in the myocardium have structural alterations of the heart and more calcifications in the coronary arteries that increase their risk of cardiovascular disease.

News

A phase I clinical trial with Vall d'Hebron participation shows good results of a drug against childhood cancer

Dr. Lucas Moreno and Dr. Constantino Sábado, researchers of the Translational Research Group in Childhood and Adolescent Cancer, are two of the leaders of the international study.

News

A program to support patients with primary immunodeficiencies at Vall d'Hebron expands to Bellvitge Hospital

The project "I have PID. I'm an adult and I'm not alone" offers telematic sessions to improve the emotional well-being of adult patients with this type of disease.

News

New platform based on human lung tissue developed for SARS-CoV-2 study to help identify potential treatments

The system can rapidly identify viral targets and the expression of viral entry factors, as well as detect inhibitors of viral entry into cells and anti-inflammatory compounds.

News

The eye as a window onto the brain: retinal changes in diabetic patients could reflect the risk of cognitive impairment

Identifying the common pathologies and molecular mechanisms involved in retinal and brain neurodegeneration could open up new opportunities in preventing type 2 diabetes-related cognitive impairment.

News

The pre-enrollment for the 9th edition of Translational Biomedical Research Master at VHIR is now open

The pre-enrollment period for the 2022-2023 academic year of the Master in Translational Biomedical Research at VHIR will be open from January 10 to September 5, 2022, or until all places are filled.

News

Dr. Ferran Pellisé receives the Hibbs Award for research on spinal deviations

The Scoliosis Research Society (SRS) has awarded with this prestigious recognition Dr. Pellisé's team for the study on the similarity of the adverse effects of surgeries both in elderly patients and in the general adult population.

News

Hakima Ouaarab, researcher at Vall d'Hebron, awarded by the journal Metas de Enfermería

The project COCREA SASI. Co creation for the promotion of affective-sexual health from an intercultural perspective has won the award for Best Research Paper.

News

Vall d’Hebron tests the efficacy of a drug to treat neuroblastoma, a highly aggressive form of paediatric tumour

The study shows the therapeutic effect of a new drug called 4SC-205 in new mouse neuroblastoma models, where it is effective in reducing the growth of the tumour.

News

Vall d'Hebron, a reference in care and research in enterovirus infection

This year, the Vall d'Hebron team has participated in the publication of three articles to understand the 2016 enterovirus A71 (EV-A71) outbreak in Catalonia and the follow-up of non-polio enteroviruses today.

News

The foundation Amics Joan Petit Children with Cancer donate € 65,000 for research in childhood cancer

The solidarity activities of the foundation allow them to raise more money every year for the research of this disease.

News

Vall d'Hebron lidera un estudi internacional per millorar el maneig de pacients amb COVID-19 que necessiten oxigenació extracorpòria

L'estudi ECMOVIBER, realitzat a partir de 338 pacients que han rebut suport amb ECMO per una infecció per coronavirus greu a 24 centres d'Espanya i Portugal, detecta els factors associats amb una major mortalitat hospitalària.

News

Vall d’Hebron presenta la mostra ‘Ultrasons, de la natura a la medicina’ al CosmoCaixa

Des del 27 de desembre fins al 9 de gener de 2022 es podrà visitar a la sala Àgora del CosmoCaixa.

News

Eva Baldrich has received a CaixaResearch Consolidate 2021 grant

With this grant the project Synthetic cells to improve the control of viral infections will receive support to accelerate its arrival to society.

News

IrsiCaixa i Vall d’Hebron mapen el reservori del VIH i descriuen l’atles de les cèl·lules on s’amaga el virus

És el primer cop que s’analitzen totes les cèl·lules que conformen el reservori del VIH a la sang a la vegada, descrivint de quina manera i en quins subtipus de cèl·lules en concret s’ubica aquest reservori en persones que reben tractament antiretroviral   &nb

News

Researchers describe a mechanism that hinders cancer cells proliferation and induces their death

Vall d’Hebron and UAB researchers studied the antitumoral action of protein kinase ERK5 inhibitor drugs, and found out they accelerate toxic autophagy.